Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

December 31, 2023

Conditions
Primary Open Angle Glaucoma
Interventions
DIETARY_SUPPLEMENT

GlaucoCetin

GlaucoCetin, a medical food in capsule form, is FDA regulated and includes ingredients that have been shown to support and protect mitochondrial function of retinal ganglion cells. GlaucoCetin consists of a mixture of Curcumin, N-Acetyl Cysteine, Ginkgo Biloba Extract, Alpha-lipoic Acid, Citicoline, Grape Seed Extract, Green Tea Extract, and Coenzyme Q10. Additional ingredients include L-Taurine, Niacinamide, Biotin, Natural Astaxanthin, Fisetin, Quercetin, Luteolin, Proprietary Dragonberry Flavor Complex, Monk Fruit, Bitter Blocker Natural Flavor, Citric Acid, Silica Dioxide, Fibersol-2, L-Leucine. Many of these are known anti-inflammatory and antioxidant ingredients. A 6 month supply of capsules, made for this study, will be provided at randomization with the following instructions: Take 6 capsules by mouth once daily with food.

OTHER

Placebo

The placebo is an identical capsule to the GlaucoCetin, made for this study, with no nutritional value. A 6 month supply of capsules will be provided at randomization with the following instructions: Take 6 capsules by mouth once daily with food.

Trial Locations (1)

19107

RECRUITING

Wills Eye Hospital, Glaucoma Research Center, Philadelphia

Sponsors
All Listed Sponsors
collaborator

Guardian Health Sciences, Inc.

UNKNOWN

lead

Wills Eye

OTHER